Erik Bertoletti

702 total citations
17 papers, 441 citations indexed

About

Erik Bertoletti is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Erik Bertoletti has authored 17 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in Erik Bertoletti's work include Dementia and Cognitive Impairment Research (9 papers), Alzheimer's disease research and treatments (6 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Erik Bertoletti is often cited by papers focused on Dementia and Cognitive Impairment Research (9 papers), Alzheimer's disease research and treatments (6 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Erik Bertoletti collaborates with scholars based in Italy, Canada and Mexico. Erik Bertoletti's co-authors include Alessandro Padovani, Barbara Vicini Chilovi, Luca Rozzini, Marco Trabucchi, Marta Zaffira Conti, Ilenia Delrio, Marina Zanetti, Valentina Colonnello, Paolo Maria Russo and Georg Northoff and has published in prestigious journals such as PLoS ONE, Psychological Medicine and The American Journal of the Medical Sciences.

In The Last Decade

Erik Bertoletti

16 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Bertoletti Italy 10 252 127 80 72 64 17 441
Pier Luigi Scapicchio Italy 7 305 1.2× 104 0.8× 59 0.7× 52 0.7× 123 1.9× 12 521
R.S. Goldman United States 7 290 1.2× 158 1.2× 89 1.1× 48 0.7× 123 1.9× 20 517
Marta Zaffira Conti Italy 11 408 1.6× 198 1.6× 154 1.9× 85 1.2× 66 1.0× 19 759
Solaphat Hemrungrojn Thailand 8 240 1.0× 69 0.5× 90 1.1× 31 0.4× 55 0.9× 27 485
Michael T. Ropacki United States 10 390 1.5× 133 1.0× 109 1.4× 27 0.4× 46 0.7× 27 537
F. Latour France 12 318 1.3× 159 1.3× 124 1.6× 105 1.5× 84 1.3× 28 577
Martin Burkart Germany 18 302 1.2× 138 1.1× 79 1.0× 50 0.7× 59 0.9× 48 860
B.M. van Gelder Netherlands 6 186 0.7× 143 1.1× 33 0.4× 55 0.8× 83 1.3× 12 627
J.H. Jhoo South Korea 13 243 1.0× 128 1.0× 76 0.9× 32 0.4× 32 0.5× 22 531
A. Pfeffer Poland 8 232 0.9× 146 1.1× 63 0.8× 25 0.3× 36 0.6× 14 443

Countries citing papers authored by Erik Bertoletti

Since Specialization
Citations

This map shows the geographic impact of Erik Bertoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Bertoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Bertoletti more than expected).

Fields of papers citing papers by Erik Bertoletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Bertoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Bertoletti. The network helps show where Erik Bertoletti may publish in the future.

Co-authorship network of co-authors of Erik Bertoletti

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Bertoletti. A scholar is included among the top collaborators of Erik Bertoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Bertoletti. Erik Bertoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Maietti, Elisa, Erik Bertoletti, Filippo Trapani, et al.. (2023). Healthcare-associated infections and antimicrobial resistance in severe acquired brain injury: a retrospective multicenter study. Frontiers in Neurology. 14. 1219862–1219862. 3 indexed citations
3.
Colonnello, Valentina, et al.. (2021). One size does not fit all: individual differences in attachment style and fear of COVID‐19 in hospitalized elderly patients. Psychogeriatrics. 21(5). 848–849. 1 indexed citations
4.
Colonnello, Valentina, et al.. (2020). Psychological distress in hospitalized patients without COVID-19 symptoms: the role of fear of infection and remote contact with informal caregivers. Psychological Medicine. 53(1). 297–298. 25 indexed citations
5.
Bertoletti, Erik, et al.. (2016). Morfeo Study II: Clinical Course and Complications in Patients With Long-Term Disorders of Consciousness. The American Journal of the Medical Sciences. 351(6). 563–569. 6 indexed citations
7.
8.
Conti, Marta Zaffira, Marina Zanetti, Salvatore Caratozzolo, et al.. (2010). Does Age at Observation Time Affect the Clinical Presentation of Mild Cognitive Impairment?. Dementia and Geriatric Cognitive Disorders. 30(3). 212–218. 6 indexed citations
9.
Rozzini, Luca, Barbara Vicini Chilovi, Marta Zaffira Conti, et al.. (2009). Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. International Psychogeriatrics. 22(1). 114–119. 49 indexed citations
10.
Rozzini, Luca, Barbara Vicini Chilovi, Erik Bertoletti, et al.. (2008). The Importance of Alzheimer Disease Assessment Scale-cognitive Part in Predicting Progress for Amnestic Mild Cognitive Impairment to Alzheimer Disease. Journal of Geriatric Psychiatry and Neurology. 21(4). 261–267. 28 indexed citations
11.
Chilovi, Barbara Vicini, et al.. (2008). Serum albumin level interferes with the effect of Donepezil in Alzheimer’s disease. Aging Clinical and Experimental Research. 20(6). 509–512. 6 indexed citations
12.
Rozzini, Luca, Barbara Vicini Chilovi, Erik Bertoletti, Marco Trabucchi, & Alessandro Padovani. (2007). Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer’s Disease. Aging Clinical and Experimental Research. 19(3). 220–223. 23 indexed citations
13.
Rozzini, Luca, Barbara Vicini Chilovi, Marta Zaffira Conti, et al.. (2007). Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. International Journal of Geriatric Psychiatry. 22(12). 1217–1222. 134 indexed citations
14.
Rozzini, Luca, Barbara Vicini Chilovi, Erik Bertoletti, et al.. (2007). Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. International Psychogeriatrics. 20(1). 86–95. 20 indexed citations
15.
Rozzini, Luca, Barbara Vicini Chilovi, Erik Bertoletti, et al.. (2007). Cognitive and Psychopathologic Response to Rivastigmine in Dementia With Lewy Bodies Compared to Alzheimer’s Disease: A Case Control Study. American Journal of Alzheimer s Disease & Other Dementias®. 22(1). 42–47. 21 indexed citations
16.
Rozzini, Luca, Barbara Vicini Chilovi, Erik Bertoletti, et al.. (2006). Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. International Journal of Geriatric Psychiatry. 21(6). 550–555. 76 indexed citations
17.
Rozzini, Luca, Barbara Vicini Chilovi, Giuseppe Bellelli, et al.. (2005). Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. International Journal of Geriatric Psychiatry. 20(6). 547–551. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026